ABC aired a special from Oprah Winfrey last night about how new GLP-1 drugs are helping patients and changing the perception of obesity as a disease rather than a failure of willpower, giving even more exposure to Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. Read the full article here.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us